George Koshy Vilanilam, MBBS


George Koshy Vilanilam, MBBS: Migraine as a Risk Factor for Ischemic Stroke

The study found that there has been a significant increasing trend in patients with migraine—irrespective of aura status—having an ischemic stroke.

Elizabeth Ross, MD, PhD


Elizabeth Ross, MD, PhD: Improving the Field By Understanding Mechanisms

The director of the Center of Neurogenetics at Weill Cornell Medicine spoke about the wealth of improvements that have really turned this area of medicine into a much more hopeful one.

John Didsbury, PhD


John Didsbury, PhD: Going Against the Grain in Established Alzheimer

The founder and CEO of T3D Therapeutics, Inc., spoke about T3D’s desire to go against the grain and trend in the therapeutic development for mild to moderate Alzheimer disease.

Jeremy Payne, MD, PhD


Jeremy Payne, MD, PhD: The Lack of Progress for Telestroke

The director of the Stroke Center at Banner-University Medicine Neuroscience Institute spoke to the need for data like that from the TELECAST study and how the COVID-19 pandemic might push telestroke care forward.

Nir Lipsman, MD, PhD


Nir Lipsman, MD, PhD: Innovations in Alzheimer Disease

The neurosurgeon from Sunnybrook Health Sciences Centre spoke about his excitement about where the medical community is at, at this point, in the understanding of Alzheimer disease.

Michael J. Polydefkis, MD


Future Treatment of hATTR Amyloidosis

Analysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.

Joseph Berger, MD


Joseph Berger, MD: The Role of Artificial Intelligence in Neurology

The associate chief of the MS division and professor of neurology at Penn Medicine described the ongoing relationship between artificial intelligence and neurologists, and how it may evolve in the future.

Brenda L. Banwell, MD


Differences in Effective Therapies for Pediatric versus Adults with MS: Brenda Banwell, MD

The chief of neurology and codirector of the neuroscience Center at the Children's Hospital of Philadelphia spoke at ECTRIMS 2022 about the difference in conversation for therapies between pediatric patients and adult patients with MS. [WATCH TIME: 5 minutes]

Kevin Kunzmann


FDA Approves Pfizer COVID-19 Vaccine for Those Ages 16 Years and Older

The full approval for BNT162b2 (Comirnaty; Pfizer/BioNTech) will afford physicians greater prescribing capability and is expected to play a role in driving workplace vaccine mandates.

Francois Bethoux, MD


The Case for Neurorehabilitation

Neurological rehabilitation, or neurorehabilitation, can be described as the use of rehabilitation interventions to improve or maintain function and quality of life in the context of neurological conditions.

Alberto Espay, MD, MSc


Significant Impact of Carbidopa Levodopa Agent ND0162 in Parkinson Disease

The director of the James J. and Joan A. Gardner Family Center discussed data from the phase 3 BouNDlesstrial assessing a continuous, subcutaneous levodopa/carbidopa delivery system for patients with Parkinson disease experiencing motor fluctuations. [WATCH TIME: 3 minutes]

P. James B. Dyck, MD


Future Treatment of hATTR Amyloidosis

Analysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.

Jeff D. Williamson, MD, MHS


Jeff D. Williamson, MD, MHS: SPRINT-MIND Trial Preliminary Results

The SPRINT MIND trial found a statistically significant lower rate of new cases of mild cognitive impairment in the intensive treatment group.

Elzbieta Kuzma, PhD


Elzbieta Kuzma, PhD: Healthy Lifestyle Reduces Dementia Risk Despite Genetics

The research fellow at the University of Exeter spoke about the findings from her observational study which showed that living a favorable lifestyle could offset the risk for dementia, even if that risk is genetically linked. 

Michael J. Thorpy, MD


Unmet Needs in Narcolepsy and Clinical Pearls

Neurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.

Amy Sullivan, PysD


Amy Sullivan, PysD: Team-Based Approach to MS

The director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about the importance of caring for patients with MS by using a team-based approach.

Michael R. Sperling, MD


Paroxysmal Abnormalities in the Brain and Defining the ‘Seizure’: Michael Sperling, MD

At the 2022 AES Conference, the Baldwin Keyes professor of neurology at Thomas Jefferson University, talked about what defines a ‘seizure’ and changing the terminology. [WATCH TIME: 5 minutes]

J. Eric Pina-Garza, MD


J. Eric Pina-Garza, MD: Increasing the Awareness of Epilepsy

The director of Pediatric Epilepsy at Centennial Children's Hospital spoke about the need to increase epilepsy's awareness and the clinical development of several agents that he is keeping his eyes on.

Lilyana Amezcua, MD


Lilyana Amezcua, MD: Better Understanding MS in the Hispanic Community

The associate professor of clinical neurology spoke about the need to understand modifiable social and cultural factors that could impact disease severity and progression.

Hannah Cock, MD, MBBS


Hannah Cock, MD, MBBS: Challenges in Treating Status Epilepticus

The professor of epilepsy and medical education at St. George’s University Hospital London spoke about the number of challenges plaguing epileptologists when treating patients who present with possible status epilepticus in the hospital.

Christina M. Ohnsman, MD


Rare Neurologic Diseases Are Not Truly Rare

Despite being labeled as rare diseases, a number of neurologic conditions impact more patients than most would believe. The consultant with expertise in ophthalmology, gene therapy, and rare and orphan diseases, chimed in about how these diseases can often be overlooked.

Sumeet Vadera, MD


Sumeet Vadera, MD: Advances in Epilepsy Surgery

The director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke to the advances that have been made in epilepsy surgery and in noninvasive or minimally invasive techniques, as well as the impact they’ve had on outcomes.

Rebecca Stainman, MD


Rebecca Stainman, MD: Identifying, Addressing Physician Burnout

The child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.

Samantha Budd Haeberlien, PhD


Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug Development

Haeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.

Costantino Iadecola, MD


Associations Between Organ Health and Brain Function, Preserving Brain Health: Costantino Iadecola, MD

The director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine spoke about preserving brain function through medical, sociopolitical, and educational efforts as part of his presentation at the 2023 AAN annual meeting. [WATCH TIME: 6 minutes]

© 2023 MJH Life Sciences

All rights reserved.